Across TCGA pan-cancer cohorts, TMEM167B RNA differs between tumor and matched normal tissue in 10 of 18 cancer types tested, making tumor–normal expression one of TMEM167B’s most consistent transcriptional readouts.
The strongest signal is observed in thyroid carcinoma (THCA), where TMEM167B RNA is repressed in tumor relative to normal tissue. In most cancer types TMEM167B is over-expressed in tumor, although a few such as THCA and KICH show the opposite, repressed pattern.
THCA, LIHC, and KICH are the cancer types where TMEM167B tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in TMEM167B RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.